Clinics in Dermatology
Volume 27, Issue 2 , Pages 175-194 , March 2009

Antioxidant use in nutraceuticals

  • Umberto Cornelli, MD

      Affiliations

    • Corresponding Author InformationPiazza Novelli 5, 20123 Milan, Italy. Tel.: +39 02 70121867.

References 

  1. Food and Nutrition Board, Institute of Medicine . Dietary reference intakes. Washington (DC): National Academy Press; 2002;
  2. Comroe JH, Dripps RD, Dumke PR, Deming M. Oxygen toxicity. JAMA. 1945;128:707–710
  3. Nash G, Blennerhasset JB, Pontoppidan H. Pulmonary lesions associated with oxygen therapy and artificial ventilation. N Eng J Med. 1967;276:368–374
  4. Zitnanova I, Korytar P, Aruoma OI, et al. Uric acid and allantoin levels in Down syndrome: antioxidant and oxidative mechanism?. Clin Chim Acta. 2004;341:139–146
  5. Das S, Engelman RM, Maulik N, Das DK. Angiotensin preconditioning of the heart: evidence for redox signaling. Cell Biochem Biophys. 2006;44:103–110
  6. Hung YC, Hong MY, Huang GS. Cholesterol augments oxidative stress in macrophages. FEBS Lett. 2006;580:849–861
  7. Cicco G, Panzera PC, Catalano G, Memeo V. Microcirculation and reperfusion injury in organ transplantation. Adv Exp Med Biol. 2005;566:563–573
  8. Campise M, Bamonti F, Novembrino C, et al. Oxidative stress in kidney transplantation. Transplantation. 2003;76:1474–1478
  9. Katz MA. The expanding role of oxygen free radicals in clinical medicine. West J Med. 1986;144:441–446
  10. Grisham MB. Oxidants and free radicals in inflammatory bowel disease. Lancet. 1994;344:859–861
  11. Stadtman ER, Oliver CN. Metal-catalyzed oxidation of proteins. J Biol Chem. 1991;266:2005–2008
  12. Hertog MG, Feskens EJ, Hollman PC, et al. Dietary antioxidants flavonoids and risk of coronary heart disease: the Zutphen elderly study. Lancet. 1993;32:1007–1011
  13. Hirvonen T, Pietinen P, Virtanen M, et al. Intake of flavonols and flavones and risk of coronary heart disease in male smokers. Epidemiology. 2001;12:62–67
  14. Dizdaroglu M, Jaruga P, Birincioglu M, Rodriguex H. Free radical–induced damage to DNA: mechanism and measurement. Free Radic Biol Med. 2002;32:1102–1115
  15. Chevion M, Berenshtein E, Stadtman ER. Human studies related to protein oxidation: protein carbonyl content as a marker of damage. Free Radic Res. 2000;33:S99–S108
  16. Cesarone MR, Belcaro G, Carratelli M, et al. A simple test to monitor oxidative stress. Int Angiol. 1999;18:127–130
  17. Schimke I, Kahl PE, Romaniuk P, Papies B. Concentration of thiobarbituric acid reactive substances (TBARS) in serum following myocardial infarction. Klin Wochenschr. 1986;64:1237–1239
  18. Lima ES, Di Mascio P, Rubbo H, Abdalla DS. Characterization of linoleic acid nitration in human blood plasma by mass spectrometry. Biochemistry. 2002;41:10717–10722
  19. Liu J, Yeo HC, Doniger SJ, Ames BN. Assay of aldehydes from lipid peroxidation: gas chromatography–mass spectrometry compared to thiobarbituric acid. Annal Biochem. 1997;245:161–166
  20. Lang J, Celotto C, Esterbauer H. Quantitative determination of the lipid peroxidation product 4-hydroxynonenal by high performance liquid chromatography. Anal Biochem. 1985;150:369–378
  21. Montuschi P, Barnes PJ, Roberts LJ. Isoprostanes markers and mediators of oxidative stress. FASEB. 2004;18:1791–1800
  22. Montine TJ, Quinn JF, Milatovic D, et al. Peripheral F2-isoprostanes and F-4 isoprostanes are not increased in Alzheimer's disease. Ann Neurol. 2003;53:175–179
  23. Varma SD, Devamanoharan PS. Excretion of hydrogen peroxide in human urine. Free Radic Res Commun. 1990;8:73–78
  24. Knutson MD, Handelman GJ, Viteri FE. Methods for measuring ethane and pentane in expired air from rats and humans. Free Radic Biol Med. 2000;28:514–519
  25. Radi R, Peluffo G, Alvarez MN, et al. Unraveling peroxynitrite formation in biological systems. Free Radic Biol Med. 2001;30:463–468
  26. Clermont G, Vergely C, Jazayeri S, et al. Systemic free radical activation is a major event involved in myocardial oxidative stress related to cardiopulmonary bypass. Anesthesiology. 2002;96:80–87
  27. Ingelman-Sundberg M, Kaur H, Terelius Y, et al. Hydroxylation of salicylate by microsomial fraction and cytochrome P-450. Lack of production of 2,3-dihydroxybenzoate unless hydroxyl radical formation is permitted. Biochem J. 1991;276:753–757
  28. Aejmelaeus RT, Holm P, Kaukine U, et al. Age-related changes in the peroxyl radical scavenging capacity of human plasma. Free Radic Biol Med. 1997;23:69–75
  29. Winston GW, Regoli F, Dugas AJ, et al. A rapid gas chromatographic assay for determining oxyradical scavenging capacity of antioxidants and biological fluids. Free Radic Biol Med. 1998;24:480–493
  30. Moison RM, de Baufort AJ, Haasnoot AA, et al. Uric acid and ascorbic acid redox ratio in plasma and tracheal aspirate of preterm babies with acute and chronic lung disease. Free Radic Biol Med. 1997;23:226–234
  31. Mikami T, Tomita S, Qu GJ, et al. Is allantoin in serum and urine a useful indicator of exercise-induced oxidative stress in humans?. Free Radic Res Med. 2000;32:235–244
  32. Miller NJ, Rice-Evans C, Davies MJ, et al. A novel method for measuring antioxidant capacity and its application on monitoring the antioxidant status in premature neonates. Clin Sci. 1993;84:407–412
  33. Benzie IF, Strain JJ. Ferric reducing ability of plasma (FRAP) as a measure of “antioxidant power”: the FRAP assay. Anal Biochem. 1996;239:70–76
  34. Cao G, Prior RL. Measurement of oxygen radical absorbance capacity in biological samples. Methods Enzymol. 1999;299:50–62
  35. Schleiser K, Harwat M, Bohm V, Bitsch R. Assessment of antioxidant activity by using different in vitro methods. Free Radic Res. 2002;36:177–187
  36. Nakamura H, Vaage J, Valev , et al. Measurement of plasma glutaredoxin and thioredoxin in healthy volunteers and during open hearth surgery. Free Radic Biol Med. 1998;24:1176–1186
  37. Hirai N, Kawano H, Yasue H, et al. Attenuation of nitrate tolerance and oxidative stress by an angiotensin II receptor blocker in patients with coronary spastic angina. Circulation. 2003;108:1446–1450
  38. Halliwell B, Whiteman M. Measuring reactive species and oxidative damage in vivo and in cell culture: how should you do it and what do results mean?. Br J Pharmac. 2004;142:231–255
  39. Mayne ST. Antioxidant nutrients and chronic disease: use of biomarkers of exposure and oxidative stress status in epidemiological research. J Nutr. 2003;133:933S–940S
  40. Mathews CK, van Hole KE. Biochimica Casa Editrice Ambrosiana-Milano. Seconda edizione 2002: 523-6.
  41. Vertuani S, Angusti A, Manfredini S. The antioxidant and pro-antioxidant network. Curr Phamac Des. 2004;10:1677–1694
  42. Manach C, Scalbert A, Morand C, et al. Polyphenols: food sources and bioavailability. Am J Clin Nutr. 2004;79:727–747
  43. Carr AC, Zhu BZ, Frei B. Potential antiatherogenic mechanism of ascorbate (vitamin C) and a-tocopherol (vitamin E). Circ Res. 2000;87:349–354
  44. Diaz MN, Frei B, Vita JA, Keaney JF. Antioxidants and atherosclerotic hearth disease. N Engl J Med. 1997;7:408–416
  45. Ervin RB, Wright JD, Wang CY, Kennedy-Stephenson J. Dietary intake of selected vitamins for the United State population: 1999-2000. Adv Data. 2004;339:1–8
  46. Cornelli U, Terranova R, Luca S, et al. Bioavailability and antioxidant activity of some food supplements in man and women using D-Roms test as a marker of oxidative stress. J Nutr. 2001;131:3208–3211
  47. Nelson JL, Berstein PS, Schmidt MC, et al. Dietary modification and moderate antioxidant supplementation differentially affect serum carotenoids, antioxidant levels and markers of oxidative stress in older humans. J Nutr. 2003;1:3117–3123
  48. Jacob RA, Aiello GM, Stephensen CB, et al. Moderate antioxidant supplementation has no effect on biomarkers of oxidant damage in healthy men with low fruit and vegetable intakes. J Nutr. 2003;133:740–743
  49. Porkkala-Sarataho E, Salonen TJ, Nyyssönen K, et al. Long-term effects of vitamin E, vitamin C, and combined supplementation on urinary 7-hydro-8-Oxo-2¢-deoxyguanosine, serum cholesterol oxidation products, and oxidation resistance of lipids in nondepleted men. Arterioscler Thromb Vasc Biol. 2000;20:2087–2093
  50. Halvorsen BL, Holte K, Mari CW, et al. A systematic screening of total antioxidant in dietary plants. J Nutr. 2002;132:461–471
  51. Svilaas A, Sakhi AK, Frost Andersen L, et al. Intakes of antioxidant in coffee, wine, and vegetables are correlated with plasma carotenoids in humans. J Nutr. 2004;134:562–567
  52. Rimm EB, Stampfer MJ, Ascherio A, et al. Vitamin E consumption and risk of coronary artery disease in man. N Engl J Med. 1993;328:1450–1456
  53. Chambless LE, Folson AR, Davis V, et al. Risk factors progression of common carotid atherosclerosis. The Atherosclerotic Risk in Communities Study, 1987-1988. Am J Epidemiol. 2002;155:30–47
  54. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. The Alpha-Tocopherol Beta Carotene Cancer Prevention Study Group. N Eng J Med. 1994;330:1029–1035
  55. Fraser GE, Beeson WL, Phillips RL. Diet and lung cancer in California Seventh-day Adventists. Am J Epidemiol. 1991;133:683–693
  56. Pietinen P, Rimm EB, Korkonen P, et al. Intake of dietary fiber and risk of coronary heart disease in a cohort of Finnish men. The Alpha-Tocopherol, Beta-Carotene Cancer prevention Study. Circulation. 1996;94:2720–2727
  57. Rohan TE, Jain M, Howe GR, Miller AB. A cohort study of dietary carotenoids and lung risk in women (Canada). Cancer Cause Control. 2002;13:231–237
  58. Knet P, Reunanen A, Jarvine R, et al. Antioxidant vitamin intake and coronary mortality in a longitudinal population study. Am J Epidemiol. 1994;138:1180–1189
  59. Barefoot JC, Larsen S, von der Lieth L, Schroll M. Hostility, incidence of acute myocardial infarction, and mortality in a sample of older Danish men and women. Am J Epidemiol. 1995;42:477–484
  60. Stampfer MJ, Hennekens CH, Manson JE, et al. Vitamin E consumption and risk of coronary disease in women. N Engl J Med. 1993;328:1444–1449
  61. Zhang S, Hunter DJ, Forman MR, et al. Dietary carotenoids and vitamin A, C, and E and risk of breast cancer. J Natl Cancer Inst. 1999;9:547–556
  62. Grodstein F, Chen J, Wllet WC. High-dose antioxidant supplements and cognitive function in community-dwelling elderly women. Am J Clin Nutr. 2003;77:975–984
  63. Cho E, Spigenman D, Hunter DJ, et al. Premenopausal intakes of vitamin A, C, and E, folate, and carotenoids, and risk of breast cancer. Cancer Epidemiol Biomarkers Prev. 2003;12:713–720
  64. The World Health Organization MONICA Project (monitoring trends and determinants in cardiovascular disease): a major international collaboration. WHO MONICA Project Principal Investigator. J Clin Epidemiol. 1988;41:105–114
  65. Losonczy KG, Harris TB, Havlik RJ. Vitamin E and vitamin C supplement use and risk of all-cause coronary heart disease mortality in older persons: the Established Population for Epidemiologic Studies of the Elderly. Am J Cil Nutr. 1996;64:190–196
  66. Pandet DK, Shekelle R, Selwyn BJ, et al. Dietary vitamin C and beta-carotene and risk of death in middle-aged men. The Western Electric Study. Am J Epidemiol. 1995;142:1269–1278
  67. Steinmetz KA, Potter JD, Folsom AR. Vegetables, fruits, and lung cancer in the Iowa Women's Health Study. Cancer Res. 1993;53:536–543
  68. Sahyoun NR, Jacques PF, Russell RM. Carotenoids, vitamin C and E, and mortality in an elderly population. Am J Epidemiol. 1996;144:501–511
  69. Fraser GE. Diet and coronary hearth disease: beyond dietary fats and low-density-lipoprotein cholesterol. Am J Clin Nutr. 1994;59:1117S–1123S
  70. Klipstein-Grobush K, Gelejinse JM, den Breeijen JH, et al. Dietary antioxidants and risk of myocardial infarction in the elderly: the Rotterdam Study. Am J Clin Nutr. 1999;69:261–266
  71. Engelhart MJ, Geerlings MI, Ruitemberg A, et al. Dietary intake of antioxidants and risk of Alzheimer disease. JAMA. 2002;287:3223–3229
  72. Pan SY, Ugnat AM, Mao Y, et al. A case-control study of diet and the risk of ovarian cancer. Cancer Epidemiol Biomarkers Prev. 2004;13:1521–1527
  73. Montonen J, Knekt P, Järvinen R, Reunanen A. Dietary antioxidant intake and risk of type II diabetes. Diabetes Care. 2004;27:362–366
  74. Hercberg S, Galan P, Preziosi S, et al. The SU.VI.MAX Study: a randomized, placebo-controlled trial of the health effects of antioxidant vitamins and minerals. Arch Intern Med. 2004;164:2335–2342
  75. Zureik M, Galan P, Bertrais S, et al. Effect of long term daily low-dosage supplementation with antioxidants vitamins and minerals on structure and function of large arteries. Arterioscler Thromb Vasc Biol. 2004;24:1485–1491
  76. Millen AE, Klein R, Folsom AR, et al. Relation between intake of vitamin C and E and risk of diabetic retinopathy in the Atherosclerotic Risk in Communities Study. Am J Clin Nutr. 2004;79:865–873
  77. Zandi PP, Antony JC, Khachaturian AS, et al. Reduced risk of Alzheimer disease in users of antioxidant vitamin supplements: the Cache County Study. Arch Neurol. 2004;61:82–88
  78. Neuhouser ML, Patterson RE, Thornquist MD, et al. Fruits and vegetables are associated with lower lung cancer risk only in the placebo arm of the beta-carotene and retinol efficacy trial (CARET). Cancer Epidemiol Biomarkers Prev. 2003;12:350–358
  79. Chen J, Hamm L, Batuman V, Whelton PK. Serum antioxidant vitamins and blood pressure in the United States population. Hypertension. 2002;40:810–816
  80. Ford ES, Mokdad AH, Giles WH, Brown DW. The metabolic syndrome and antioxidant concentrations. Finding from the third National Health and Nutrition Examination Survey. Diabetes. 2003;52:2346–2352
  81. Botterweck AA, van der Brandt PA, Goldbohm RA. Vitamins, carotenoids, dietary fiber, and the risk of gastric carcinoma: results from a prospective study after 6.3 years of follow-up. Cancer. 2000;88:743–748
  82. Zeegers MP, Goldbohm RA, van der Brandt PA. Are retinol, vitamin C, vitamin E, folate and carotene intake associated with bladder cancer risk? Result from Netherlands Cohort Study. Br J Cancer. 2001;85:977–983
  83. Salonen RM, Nyyssönen K, Kaikkonen J, et al. Six-years effect of combined vitamin C and E supplementation on atherosclerotic progression. The Antioxidant Supplementation on Atherosclerotic Progression. Circulation. 2003;107:947–953
  84. MRC/BHF Hearth Protection Study on antioxidant vitamin supplementation in 20536 high-risk individuals: a randomized placebo-controlled trial. Lancet. 2002;360:23–33
  85. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E and beta carotene for age related cataract and vision loss: AREDS report no. 9. Arch Ophthalmol. 2001;119:1439–1452
  86. Knekt P, Ritz J, Pereira MA, et al. Antioxidant vitamins and coronary heart disease: a pooled analysis of 9 cohort. Am J Clin Nutr. 2004;80:1508–1520
  87. Cho E, Hunter D, Spieglmann D, et al. Intakes of vitamin A, C and E and folate and multivitamins and lung cancer: a pooled analysis of 8 prospective studies. Int J Cancer. 2006;118:970–978
  88. Feskanich D, Ziegler RG, Michaud DS, et al. Prospective study of fruit and vegetable consumption and risk of lung cancer among men and women. J Natl Can Inst. 2000;92:1812–1823
  89. Omenn GS, Goodman GE, Tornquist MK, et al. Effects of combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. N Eng J Med. 1996;334:1150–1155
  90. Graeme JH, Norman PE, Eikelboom JW. Medical treatment of peripheral arterial disease. JAMA. 2006;295:547–553
  91. getABI Study group. getABI: German epidemiological trial on ankle-brachial index for elderly patients in family practice to detect peripheral arterial disease, significant marker for high mortality. Vasa. 2002;31:241–248

 The author has no interests in any of the methods used to determine oxidative stress. The author is an executive manager of a company that develops antioxidants for the European Market.

PII: S0738-081X(08)00011-4

doi: 10.1016/j.clindermatol.2008.01.010

Clinics in Dermatology
Volume 27, Issue 2 , Pages 175-194 , March 2009

Article Tools

* Image Usage & Resolution